MENU
Home Campaign Promise Leadership + Impact Investment Priorities Spotlights
Make a difference today.
Donate.

For the Future of

Cardiac

Care

The Campaign for NewYork-Presbyterian

A young woman in a softball uniform and catcher's equipment.

A 38-year-old construction worker in Queens, who seems to be in perfect health.

A softball player in her junior year at Fordham.

A grandmother of five in Washington Heights, getting ready for a holiday dinner.

Any one of these people could be at risk for a major cardiac event, and no one will know until it’s too late.

But it doesn’t have to be this way. And together, we can create a different, better future for all.

At NewYork-Presbyterian Hospital, we’re making advances that will keep each one of them alive and healthy. With innovations in technology and procedures, we will:

Someone in America dies from cardiovascular disease every 36 seconds. Each year, 17.9 million people worldwide die from cardiovascular diseases, comprising 31 percent of all deaths. Heart disease is the leading cause of death in women.

With your support, we can build the tools of the future today: catching conditions before they become serious, learning more about how they affect different populations, and creating specially designed treatment plans for each individual patient—from prevention, to diagnosis and treatment, and if necessary, surgery and transplant and post-surgical care.

Learn more about the campaign
Learn more about the campaign

NYP: Harnessing Technology and Innovation to Broaden Access to the Best Care

Cardiovascular disease remains the leading cause of mortality and morbidity worldwide. The vast amounts of data generated in this field are ideally suited for artificial intelligence, enabling more accurate interpretation, predictive insights, and easing the burden on cardiologists as they focus on patient care.”

A woman with navy suit jacket.

Ashley Beecy, MD, FACC

Medical Director for Artificial Intelligence (AI) Operations, NewYork-Presbyterian

Assistant Professor of Medicine, Division of Cardiology, Weill Cornell Medicine

Medicine is about taking science and applying it in the real world where things are messy and people have many challenges. It’s the translation of something that’s theoretical to something that’s actual. And the daily practice of that is a humbling one.

[Still,] there’s a part of me that’s restless, that says, 'This isn’t good enough. This isn’t the way things ought to be.' … We can do more; we can do better. These new technologies give us a path to build a healthier future.”

A man in a doctor's coat and tie.

Pierre Elias, MD

Medical Director for Artificial Intelligence NewYork-Presbyterian

Assistant Professor in the Division of Cardiology and the Department of Biomedical Informatics NewYork-Presbyterian/Columbia University Irving Medical Center

We Can Save Millions

What sets NewYork-Presbyterian’s cardiac care system apart is the continuum of care that our doctors can provide. Whatever aspect of care your heart and circulatory system may need, we’re here to provide it—from prevention, to diagnosis and basic treatment, to more involved procedures—such as surgery and transplants and post-surgical care—for people facing more serious challenges.
Long before “AI” and “machine learning” became buzzwords in nearly every walk of life, NewYork-Presbyterian was developing tools and tactics to employ these new technologies in the prevention, diagnosis, and treatment of cardiovascular disease.
We have experience in a wide range of surgeries, including coronary artery bypass grafting, aortic aneurysm repair, valve sparing aneurysm repair, cardiac tumors, adult congenital heart surgery, pediatric heart surgery (we performed the first successful pediatric heart transplant in 1984), robotic heart surgery (we performed the first robotic heart surgery in 2001) and transcatheter aortic valve replacement (TAVR), which was developed right here at NYP and has become a global standard over the past twenty years. Even though we take on complex, high risk conditions like cardiac amyloidosis, diabetes-related end-stage organ damage, and HIV, we can proudly point to our excellent patient outcomes and low mortality rates.
Our heart transplant program is the largest and most experienced in the United States, and we remain leaders in the field. In 1984, we completed the first-ever successful pediatric heart transplant. We are constantly working toward new innovations, such as high-risk and multi-organ transplants; and we are pioneers in the use of Left Ventricular Assist Devices (LVAD), which help stabilize patients as they await transplant.
We are making strides against the diseases that give patients the most anxiety: dementias and progressive movement disorders, brain cancer, and epilepsy.
With the launch of our newest campaign, we will attract the greatest minds in prevention, diagnosis, treatment, surgery, transplant, and post-surgical care, advance the emerging technologies that will change the future, and expand on our existing skillset so that we can do more every day to save people from the world’s leading cause of death.
We are building the next generation of clinicians and researchers. In 2030, this field will look very different; AI will help us identify patients and even choose the right therapy. The patient will be at home and not in the hospital. There will be gene therapy we don’t have today. Our generous supporters who want to be a part of this are making it possible.”
Nir Uriel, MD, MSC, FACC
Director of Advanced Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support Programs, NewYork-Presbyterian
Seymour, Paul, and Gloria Milstein Professor of Medicine
Columbia University Irving Medical Center and Weill Cornell Medicine

With Your Support, We Can Save People Who Once Might Never Even Have Made It to the Hospital Alive.

Investment Priorities

Attracting and Supporting the World’s Most Brilliant Cardiac Minds.

  • Recruiting, retaining, and empowering the physician-scientists, surgeons, and caregivers who are defining the next frontiers of care in every cardiac service, from cardiology to cardiac surgery to heart transplants.

  • Providing advanced facilities and technology to support leading-edge work.

  • Investing in research programs and data analysis by connecting the world’s best minds with the most comprehensive, diverse set of patient data anywhere.

Bringing the Technology and Treatments of the Future to the Here and Now.

Investing in machine learning, AI, and predictive analytics to realize previously impossible aspirations in:

  • Prediction: Charting the next stage in the course of a disease with greater precision and personalization than ever. 

  • Prevention: Assessing a patient’s risk of developing heart conditions based on personal risk factors and health history and taking steps to make sure they never arise. 

  • Diagnosis: Identifying cases that would once have gone undetected by using AI-powered tools to analyze every electrocardiogram in our system and flag warning signs the human eye often misses.

  • Treatment: Analyzing all the factors in a patient’s life, from physical data to social determinants of health, and creating individual treatment plans.

  • Health Equity: Analyzing and accounting for the full diversity and potential differences of the communities we serve.

Elevating and Expanding Our Existing Capabilities.

  • Expanding our remote-monitoring program to catch life-threatening problems before they happen, adjust treatments more rapidly and precisely, and reduce the need for heart surgery. 

  • Closing the implementation gap to prevent thousands of unnecessary deaths each year, by investing in data analysis and outreach to ensure that everyone receives the treatment they need to avoid heart failure.  

  • Continuing to create brilliant innovations and pioneering treatments in the field of cardiac surgery.

  • Pioneering new approaches and alternatives to heart transplants to expand access, reduce complications, and ensure longer, healthier lives.

At Weill Cornell, we push the boundaries of clinical innovation, academic research, and our understanding of cardiovascular pathophysiology—while mentoring the next generation.”

Jonathan W. Weinsaft, MD

Chief of the Greenberg Division of Cardiology

Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

I’ve seen philanthropy transform the hospital throughout my decades-long tenure. It was essential to our becoming a top ten cardiology program in the country—few others can claim such breadth and depth.”

Allan Schwartz, MD

Chief of the Division of Cardiology
Physician-in-Chief, Vivian and Seymour Milstein Family Heart Center NewYork-Presbyterian/Columbia University Irving Medical Center

Seymour Milstein and Harold Ames Hatch Professor of Clinical Medicine Vice Chair, Department of Medicine Columbia University Vagelos College of Physicians and Surgeons

See our impact
See our impact

NYP: Leading the Way in Cardiac Care

Patient Spotlight

Sarah with her athletic trainer, Bridget Ward, who brought the defibrillator and used it to help revive Sarah when she went into cardiac arrest.

Sarah

Sarah Taffet, a 21-year-old softball player for the Fordham University Rams, was running out a routine ground ball during a tournament in Newark, New Jersey, when her opponent tagged her in the chest for the out.

She fell forward and hit the ground.

I’m so excited and so happy to be able to play my senior season,” Sara says. “‘Thank you’ doesn’t even scratch the surface of what I would like to convey to my doctors for what they have done for me and my family.”

Mati

Mati Luik was playing in his winter league tennis match in December 2019, when he felt his heart racing. He quickly lay down to avoid falling since he had collapsed on the court a year before and had to be hospitalized.

It's hard to describe the feeling, going from such a damaged heart to a new, properly functioning heart."

Mati Luik with his wife, Veronica, and daughter, Carolina.

A Tradition of Excellence,
A Bright Future

At NYP, a tradition of innovation and creativity—and most of all, of vision and optimism—has driven the development of advances that have changed the lives of so many.”

Man in a doctor's coat.

Hiroo Takayama, MD, PHD

Chief of Adult Cardiac Surgery

Director, Aortic Surgery Program

Co-Director of the Aortic Center, the Hypertrophic Cardiomyopathy Center, and the Marfan Clinic

NewYork-Presbyterian/Columbia University Irving Medical Center

Whichever surgeon they choose for whichever problem they have, they're going to get a complete commitment from the minute they walk in to the minute they walk out.”

A man in a doctor's coat and wearing a tie.

Leonard Girardi, MD

Cardiothoracic Surgeon-in-Chief, NewYork-Presbyterian/ Weill Cornell Medical Center

Attending Cardiothoracic Surgeon, NewYork-Presbyterian/ Weill Cornell Medical Center

Chair of Cardiothoracic Surgery, Weill Cornell Medical College  with Weill Cornell Medicine

O. Wayne Isom Professor of Cardiothoracic Surgery, Weill Cornell Medical College with Weill Cornell Medicine

We Make History in Moments Like These.

It’s not often that you get the opportunity to see the future. But from where we stand today, we can see that the work we are doing will save millions of lives, in New York City and across the world.

But we need your help to make that future possible.

We hope you will join us on this journey today.

For every person walking through life with an undiagnosed heart condition…

For every family who isn’t ready to lose their dad, their mom, or their child…

For every physician who desperately needs the tools we can pioneer…

For every Dream.

For every Hope.

For every future

Make a difference today.
Donate Now.
with world-class doctors from Columbia and Weill Cornell Medicine